y.asante
TL2 · Rosario
Contributes reviews on supplier material. Based in Rosario.
Joined 13 September 2025 · last posted 4d
84 posts, newest first. Showing up to 150.
-
Lipid changes during rapid weight loss: the expected trajectory Replied, post #15 · Clinical › Bloodwork · 24 Jul 2026 · 6 likes Everything in post #14 holds. The case it does not cover is the one I have. Ask what decision the result would change before ordering it. A test whose result changes…
-
Seven-day rolling means and why weekly readings mislead Replied, post #32 · Outcomes › Progress reports · 15 Jul 2026 · 25 likes Post #30 put the caveat in the right place and I want to underline it. Two people in this thread mean different things by seven-day rolling and are disagreeing about…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #59 · Evidence › Journal club · 13 Jul 2026 · 0 likes I had written a reply contradicting post #55 and deleted it. Here is what survived. Sessions on negative or null results are consistently the most instructive and the…
-
Search filters: what is missing Replied, post #80 · Meta › Site feedback · 13 Jul 2026 · 3 likes Small correction to my own earlier position on search filters. I had the units the wrong way round, which changes the conclusion by an order of magnitude and therefore…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #109 · Start Here › How to Ask · 8 Jul 2026 · 0 likes Answering the question post #105 raises rather than the one it answers. A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the…
-
Fasting versus non-fasting and which tests care Replied, post #58 · Clinical › Bloodwork · 28 Jun 2026 · 0 likes Posting my fasting versus non-fasting numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who wanted…
-
Second pass at: Programming during a large energy deficit Replied, post #19 · Nutrition & Training › Resistance training · 8 Jun 2026 · 2 likes Post #17 describes the usual case. This is about the unusual one. Recovery capacity falls with energy availability, so a programme that worked at maintenance may be too…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #70 · Practice › Storage & stability · 6 Jun 2026 · 7 likes The claim about reconstituted upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post says "causes".
-
Tracking a shortage from primary sources rather than rumour Replied, post #29 · Access › Shortages · 30 May 2026 · 25 likes I had written a reply contradicting post #27 and deleted it. Here is what survived. Both are useful and different. The notice tells you the national position; the…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #52 · Practice › Interactions · 27 May 2026 · 5 likes This is the first time the answer has come with its own limits attached. Appreciated.
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #59 · Compounds › Tirzepatide · 17 May 2026 · 0 likes Reading back through the Tirzepatide and nausea threads from last year, the same three questions come up every time and only one of them has ever been answered…
-
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #66 · Practice › Administration · 15 May 2026 · 11 likes Confirming post #63 from a second method, which matters more than confirming it from a second person. Injection discomfort: comes from needle gauge (finer = less…
-
Second pass at: A pooled estimate that changed when one trial was added Replied, post #3 · Evidence › Meta-analyses · 10 May 2026 · 1 like When a meta-analysis is unhelpful: if the included studies are heterogeneous in population, intervention, or outcome, pooling them produces a number that represents…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #132 · Analytics › Mass spectrometry · 1 May 2026 · 1 like Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by MS, because extinction coefficients are better known. MS can quantify if an internal…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #36 · Meta › Announcements · 25 Apr 2026 · 7 likes Thank you for announcing it in advance rather than after. The number of places that do the reverse is remarkable. I would want a second opinion before relying on that.
-
Personal import allowances, compared — a second dataset Replied, post #110 · Access › International · 24 Apr 2026 · 14 likes I had written a reply contradicting post #108 and deleted it. Here is what survived. The most useful thing anyone has posted about Personal import allowances in this…
-
Spike-and-recover accuracy for a peptide assay Replied, post #121 · Analytics › Method validation · 11 Apr 2026 · 3 likes Everything in post #119 holds. The case it does not cover is the one I have. Accuracy for a purity assay is usually demonstrated by spike recovery across a range.…
-
Lipase elevation without symptoms: the interpretation problem Replied, post #26 · Clinical › Bloodwork · 11 Mar 2026 · 12 likes The failure mode on lipase elevation without symptoms is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too…
-
Peer-to-peer review: what actually happens on the call — one year on Replied, post #7 · Access › Insurance & coverage · 3 Mar 2026 · 31 likes Keep every document with dates in one place. An appeal months later is assembled from whatever you kept.
-
Preprint servers and what screening they do — the long version Replied, post #3 · Evidence › Preprints · 1 Mar 2026 · 3 likes Confirming post #2 from a second method, which matters more than confirming it from a second person. Check whether it was later published: searching for the preprint's…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #42 · Analytics › Mass spectrometry · 13 Feb 2026 · 0 likes Combining a chromatographic result with a mass result is genuinely orthogonal confirmation. Either alone leaves a specific class of problem invisible, and the two…
-
Trifluoroacetate content and its consequences Replied, post #77 · Analytics › Impurities & related substances · 3 Feb 2026 · 5 likes Deletion sequences arise from incomplete coupling and are lower by one residue mass. Where they elute depends on the hydrophobicity of the residue that is missing, so…
-
Adsorptive losses at low concentration, and why dilute solutions are fragile Replied, post #9 · Practice › Storage & stability · 12 Jan 2026 · 0 likes Post #7 put the caveat in the right place and I want to underline it. Adding a reference point for adsorptive losses. Mine is a single case, collected without controls,…
-
A partial dose because the pen emptied mid-injection Replied, post #66 · Practice › Administration · 9 Jan 2026 · 27 likes Practical answer on partial dose because the pen, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide…
-
Journal club: LEADER as the historical anchor Replied, post #19 · Evidence › Journal club · 3 Jan 2026 · 1 like The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions.
-
[2026 update] Long-time reader, first-time poster Replied, post #37 · Lounge › Introductions · 29 Dec 2025 · 0 likes Worth separating Long-time reader as a question about the compound from Long-time reader as a question about the documentation. They get answered by different people…
-
Persistent vomiting and the threshold for seeking help Replied, post #89 · Safety › Adverse events · 16 Dec 2025 · 26 likes Confirming post #86 from a second method, which matters more than confirming it from a second person. Severe, persistent abdominal pain, particularly radiating to the…
-
Stepping down deliberately, and how to do it without losing progress Replied, post #20 · Practice › Dosing & titration · 27 Nov 2025 · 16 likes Post #18 and I disagree about the size of the effect, not about the direction. The most common practical error is not the schedule at all — it is losing track of which…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #18 · Access › Pricing · 17 Nov 2025 · 0 likes Comparing a licensed product's price to a research-use-only preparation's price is comparing two different things, and the difference is most of the explanation.…
-
[2026 update] What steady state means for the decision to escalate Replied, post #121 · Practice › Dosing & titration · 17 Nov 2025 · 24 likes Post #120 answers the question as asked. The question underneath it is different. Where I have landed on steady state, having got it wrong once in public: the direction…
-
Pen dose counters: what a click does and does not guarantee Replied, post #47 · Devices › Pens & autoinjectors · 15 Nov 2025 · 0 likes The residual left in a cartridge at the end is deliberate overfill and is not a dose you are entitled to extract. Attempting to recover it is where accuracy goes. The…
-
Publishing an inconvenient result: a case study — the long version Replied, post #36 · Sourcing › Independent verification · 13 Nov 2025 · 0 likes Publishing an inconvenient result has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #91 · Practice › Reconstitution · 3 Nov 2025 · 0 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #35 · Compounds › Semaglutide · 28 Oct 2025 · 1 like The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents does not automatically appear in humans, but it…
-
Sleep tracking data and its considerable limitations Replied, post #90 · Wellbeing › Sleep · 26 Oct 2025 · 0 likes I came in to disagree and I am leaving without a disagreement.
-
Freeze-thaw and why one cycle is not the same as five Replied, post #15 · Practice › Storage & stability · 26 Oct 2025 · 0 likes Where the freeze-thaw discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same sentence with…
-
Retatrutide's phase 2 heart-rate signal and how to think about it Replied, post #9 · Compounds › Retatrutide · 23 Oct 2025 · 7 likes Post #6 is the version of this I will quote in future. One addition. Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What…
-
New subcategory: rationale and scope Replied, post #87 · Meta › Announcements · 22 Oct 2025 · 22 likes One more thing on new subcategory that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the apparent…
-
Comparing two chromatograms from different laboratories, properly Replied, post #19 · Analytics › HPLC & UHPLC · 12 Oct 2025 · 0 likes Post #17 describes the usual case. This is about the unusual one. Typical suitability criteria are a replicate area relative standard deviation below about two per…
-
Tracking that stops updating and then resumes — the long version Replied, post #24 · Sourcing › Logistics · 10 Oct 2025 · 1 like Anyone deciding whether a delay is a problem should ask what would change if they waited another week. Usually the answer is nothing.
-
Compounds this community declines to help with, and why Replied, post #19 · Compounds › Other compounds · 27 Sep 2025 · 2 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #46 · Evidence › Study critique · 14 Sep 2025 · 7 likes Multiple comparisons: if a paper reports many outcomes, the chance of a spurious association by random chance is real. Pre-specification of primary outcomes matters and…
-
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #82 · Practice › Side effects · 9 Sep 2025 · 23 likes Confirming post #79 from a second method, which matters more than confirming it from a second person. The relationship between symptom burden and outcome is not what…
-
[2026 update] US compounding rules and how they changed Replied, post #35 · Regional › North America · 1 Sep 2025 · 24 likes Both are useful and different. The account tells you what happens in practice; the criterion tells you what to write. The reasoning is more useful than the number,…
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #104 · Clinical › Comorbidities · 30 Aug 2025 · 0 likes My experience of Cardiovascular risk contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's experience is…
-
History of disordered eating and why it changes the conversation Replied, post #9 · Clinical › Special populations · 18 Aug 2025 · 23 likes Extrapolating a point estimate to somebody well outside the enrolled range should be described as an extrapolation every time it is done.
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #42 · Evidence › Journal club · 15 Aug 2025 · 10 likes Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything…
-
A request that was declined, and the reasoning — a second dataset Replied, post #96 · Documentation › Wiki requests · 15 Aug 2025 · 0 likes No disagreement from me. Posting only so the question does not look ignored.
-
Are there stupid questions here? A staff answer, at length Replied, post #71 · Start Here › Welcome · 14 Aug 2025 · 31 likes Reading rather than answering, but this is the post I would point somebody at.
-
Coming back to: When "no data" is the complete and final answer Replied, post #64 · Compounds › Other compounds · 30 Jul 2025 · 8 likes Post #61 is the version of this I will quote in future. One addition. Storage guidance for the less common material is usually copied from the incretin guidance and may…
-
Sodium, potassium and magnesium when intake drops Replied, post #75 · Nutrition & Training › Hydration & electrolytes · 24 Jul 2025 · 0 likes What I would want before treating sodium as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the three are usually missing.
-
Which panel is worth repeating and which is worth ignoring Replied, post #66 · Clinical › Bloodwork · 22 Jul 2025 · 2 likes Add biological variation and analytical imprecision to that base rate and the probability of a meaningless flag on a multi-analyte panel is substantial.
-
Antibiotics and a course of something with delayed emptying Replied, post #84 · Practice › Interactions · 7 Jul 2025 · 22 likes Post #81 answers the question as asked. The question underneath it is different. Antibiotics would be much easier to settle if anyone reported the denominator. Almost…
-
A report I filed that turned out to be wrong, and the correction Replied, post #119 · Sourcing › Vendor reports · 24 Jun 2025 · 29 likes A difference inside method repeatability is not a disagreement. Saying so in your own report prevents somebody else reading it as one. Someone will know this better…
-
What a documentation review can and cannot tell you Replied, post #12 · Sourcing › Independent verification · 22 Jun 2025 · 18 likes Narrowing post #9, because the general version has more than one answer. A definition problem is doing most of the work in this documentation review discussion. Once…
-
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #31 · Devices › Cold chain · 25 May 2025 · 24 likes Airline travel sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable side, narrowly.
-
Pregnancy as an absolute contraindication Replied, post #33 · Safety › Contraindications · 18 May 2025 · 6 likes Medullary thyroid carcinoma (personal or family history) or multiple endocrine neoplasia type 2: absolute contraindication. The rodent preclinical signal is real enough…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #104 · Devices › Cold chain · 16 May 2025 · 2 likes What I would tell a new member reading about Domestic fridge temperature mapping for the first time: the confident posts are not the reliable ones, and the reliable…
-
Reading a trial's population section before its results — does this still hold? Replied, post #101 · Evidence › Trials · 14 May 2025 · 0 likes Reading the supplementary appendix is where most of the real information is, and it is where almost nobody goes. The baseline table alone answers half the…
-
Reading an MS report that only gives you a single number Replied, post #78 · Analytics › Mass spectrometry · 13 May 2025 · 0 likes Taking post #77 at face value and following it one step further. Calibration matters: a high-resolution instrument out of calibration can report mass with ppm error…
-
A well-designed study with a badly written abstract Replied, post #76 · Evidence › Study critique · 12 May 2025 · 33 likes Reading back through, this was answered upthread and I missed it. My fault.
-
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #43 · Compounds › Repair & healing peptides · 8 May 2025 · 2 likes The arithmetic in post #42 is right; the assumption feeding it is the part to check. Analytical identity of BPC-157: a 15-residue peptide with an unambiguous mass…
-
Revisiting: German, French and Dutch differences, compared Replied, post #8 · Regional › European Union · 2 Apr 2025 · 28 likes I read post #6 twice before replying, because I had assumed the opposite. Correcting a stale claim here is more valuable than adding a new one, because the stale claims…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #86 · Evidence › Journal club · 28 Mar 2025 · 0 likes Two people in this thread mean different things by SURMOUNT-1 and are disagreeing about the definition while believing they are disagreeing about the facts. Worth…
-
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #2 · Practice › Dosing & titration · 26 Mar 2025 · 8 likes Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials escalated to a target and then held that. What happens if you…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #123 · Sourcing › Vendor reports · 18 Mar 2025 · 23 likes Reports of ordinary results are more valuable than reports of remarkable ones, precisely because only the remarkable ones get posted elsewhere. The uncertainty is in…
-
Storing a pen in use versus a pen unopened Replied, post #3 · Devices › Pens & autoinjectors · 16 Mar 2025 · 7 likes The opening post put the caveat in the right place and I want to underline it. Comparing cost per milligram between a pen and a vial ignores wastage, dead volume and…
-
Retatrutide dose escalation in the published trials Replied, post #6 · Compounds › Retatrutide · 11 Mar 2025 · 11 likes Glucagon receptor agonism seems paradoxical in a weight-loss compound because glucagon raises blood glucose. The paradox resolves because glucagon agonism also…
-
Bleeding at the injection site: normal, and what to do about it — does this still hold? Replied, post #8 · Practice › Administration · 1 Mar 2025 · 0 likes Where I part company with post #6, and it is a narrow parting. If you have to inject at a different time of day than usual, that is a much smaller perturbation than it…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #101 · Compounds › Other compounds · 27 Feb 2025 · 0 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #99 · Compounds › Other compounds · 25 Feb 2025 · 2 likes Sensible. I would want the same detail before I acted on it either.
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #107 · Evidence › Journal club · 28 Jan 2025 · 12 likes Answering the SURPASS-2 question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends on how the first…
-
Coming back to: Recording a dissent on a document rather than suppressing it Replied, post #14 · Documentation › Doc review · 13 Dec 2024 · 8 likes Two questions I would want answered before drawing anything from the Recording a dissent data above: how were the cases selected, and what happened to the ones that…
-
People with a low starting BMI: where the evidence stops Replied, post #17 · Clinical › Special populations · 21 Nov 2024 · 23 likes Dedicated trials in under-studied populations are the only real remedy and several are ongoing, which is worth saying rather than speculating. I have changed my mind on…
-
EMA product information as a primary source — does this still hold? Replied, post #127 · Regional › European Union · 18 Nov 2024 · 7 likes The bit of EMA product information that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is and the…
-
Choosing which test to pay for, given a fixed budget — does this still hold? Replied, post #33 · Sourcing › Independent verification · 15 Nov 2024 · 2 likes It does not extend to lots nobody has seen, it is not a recommendation, and it says nothing about anything other than what was measured. Worth one more sentence than it…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #32 · Compounds › Repair & healing peptides · 11 Nov 2024 · 7 likes This follows post #29 rather than contradicting it. Reading a preclinical wound-healing model is well covered in the tag pages, and the older discussions are better…
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #131 · Nutrition & Training › Hydration & electrolytes · 3 Oct 2024 · 0 likes I read post #127 twice before replying, because I had assumed the opposite. Marking my uncertainty on Sodium explicitly. I am confident about the direction, much less…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #66 · Practice › Dosing & titration · 18 Sep 2024 · 7 likes The reason four-week escalation interval keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer is…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #17 · Compounds › Tirzepatide · 17 Sep 2024 · 4 likes Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent and partly because the clinical programme used a…
-
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #10 · Compounds › Secretagogues & GH axis · 14 Sep 2024 · 5 likes Reconstitution volumes in this family are often small enough that dead volume in the syringe is a meaningful fraction of the dose. A fixed-needle insulin syringe is…
-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one —… Replied, post #11 · Compounds › Oral incretins · 13 Aug 2024 · 2 likes The SOUL trial: cardiovascular outcomes trial for oral semaglutide in people with type 2 diabetes and cardiovascular disease or chronic kidney disease. It demonstrates…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #30 · Practice › Dosing & titration · 7 Jul 2024 · 25 likes Agreed, and I will stop repeating the version of this I had been repeating.
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #5 · Devices › Syringes & needles · 1 Jul 2024 · 0 likes Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are more legible for small doses. Larger barrels hold larger volumes. Choose based on…